153 related articles for article (PubMed ID: 22285925)
1. An arrayed human genomic library constructed in the PAC shuttle vector pJCPAC-Mam2 for genome-wide association studies and gene therapy.
Fuesler J; Nagahama Y; Szulewski J; Mundorff J; Bireley S; Coren JS
Gene; 2012 Apr; 496(2):103-9. PubMed ID: 22285925
[TBL] [Abstract][Full Text] [Related]
2. Construction of a PAC vector system for the propagation of genomic DNA in bacterial and mammalian cells and subsequent generation of nested deletions in individual library members.
Coren JS; Sternberg N
Gene; 2001 Feb; 264(1):11-8. PubMed ID: 11245973
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin).
Song SU; Boyce FM
Exp Mol Med; 2001 Mar; 33(1):46-53. PubMed ID: 11322486
[TBL] [Abstract][Full Text] [Related]
4. A genomic BAC library and a new BAC-GFP vector to study the holocentric pest Spodoptera frugiperda.
d'Alençon E; Piffanelli P; Volkoff AN; Sabau X; Gimenez S; Rocher J; Cérutti P; Fournier P
Insect Biochem Mol Biol; 2004 Apr; 34(4):331-41. PubMed ID: 15041017
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
[TBL] [Abstract][Full Text] [Related]
6. Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma.
Kawashima H; Ogose A; Yoshizawa T; Kuwano R; Hotta Y; Hotta T; Hatano H; Kawashima H; Endo N
Cancer Sci; 2003 Jan; 94(1):70-5. PubMed ID: 12708477
[TBL] [Abstract][Full Text] [Related]
7. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA
Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766
[TBL] [Abstract][Full Text] [Related]
9. The transduction of His-TAT-p53 fusion protein into the human osteogenic sarcoma cell line (Saos-2) and its influence on cell cycle arrest and apoptosis.
Jiang L; Ma Y; Wang J; Tao X; Wei D
Mol Biol Rep; 2008 Mar; 35(1):1-8. PubMed ID: 17206471
[TBL] [Abstract][Full Text] [Related]
10. pRb-expressing adenovirus Ad5-Rb attenuates the p53-induced apoptosis in cervical cancer cell lines.
Ip SM; Huang TG; Yeung WS; Ngan HY
Eur J Cancer; 2001 Dec; 37(18):2475-83. PubMed ID: 11720846
[TBL] [Abstract][Full Text] [Related]
11. p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines.
Aurelio ON; Kong XT; Gupta S; Stanbridge EJ
Mol Cell Biol; 2000 Feb; 20(3):770-8. PubMed ID: 10629033
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53.
Wang J; Bucana CD; Roth JA; Zhang WW
Cancer Gene Ther; 1995 Mar; 2(1):9-17. PubMed ID: 7621257
[TBL] [Abstract][Full Text] [Related]
13. Repair of DNA double-strand breaks and radiosensitivity to killing in an isogenic group of p53 mutant cell lines.
DiBiase SJ; Guan J; Curran WJ; Iliakis G
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):743-51. PubMed ID: 10524431
[TBL] [Abstract][Full Text] [Related]
14. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
[TBL] [Abstract][Full Text] [Related]
15. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.
Sandoval R; Xue J; Pilkinton M; Salvi D; Kiyokawa H; Colamonici OR
J Biol Chem; 2004 Jul; 279(31):32275-80. PubMed ID: 15169789
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral Vector-mediated Gene Transfer in Human Bladder Cancer Cell Lines.
Matsunaga W; Ichikawa M; Nakamura A; Ishikawa T; Gotoh A
Anticancer Res; 2018 Apr; 38(4):2015-2020. PubMed ID: 29599318
[TBL] [Abstract][Full Text] [Related]
17. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status.
Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G
DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587
[TBL] [Abstract][Full Text] [Related]
18. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
Idelman G; Glaser T; Roberts CT; Werner H
J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
[TBL] [Abstract][Full Text] [Related]
19. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein.
Marcellus RC; Teodoro JG; Charbonneau R; Shore GC; Branton PE
Cell Growth Differ; 1996 Dec; 7(12):1643-50. PubMed ID: 8959332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
